Search research articles
Contact Us
Filters
Showing results (181-190 of 215) with videos related to
Page
of 22
Sort By:
Tissue Antigens
|
July 1, 1997
A new HLA-B44 variant (B44BO [B*4408]) identified by serology
C Darke, J Street, H Fussell, et al.
The Journal of Rheumatology
|
December 1, 1986
Lowering of plasma isoxicam concentrations with acetylsalicylic acid
E M Grace, A A Mewa, G D Sweeney, et al.
Human Immunology
|
June 8, 2001
Analysis of the distribution of HLA-B alleles in populations from five continents
F Williams, A Meenagh, C Darke, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 19, 1999
Assessment of goiter in an area of endemic iodine deficiency
P P Smyth, C Darke, A B Parkes, et al.
European Journal of Endocrinology
|
April 1, 1996
Major histocompatibility complex class II and complement polymorphisms in postpartum thyroiditis
A B Parkes, C Darke, S Othman, et al.
BJU International
|
February 14, 2006
A double-blind randomized dose-response study comparing daily doses of 5, 10 and 15 mg controlled-release oxybutynin: balancing efficacy with severity of dry mouth
Jaques Corcos, Richard Casey, Allan Patrick, et al.
Leukemia
|
May 1, 1995
Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia
M T Dorak, G Owen, I Galbraith, et al.
Genes and Immunity
|
December 15, 2006
Non-B27 MHC associations of ankylosing spondylitis
A-M Sims, M Barnardo, I Herzberg, et al.
British Journal of Haematology
|
September 1, 2001
HFE mutations, iron deficiency and overload in 10,500 blood donors
H A Jackson, K Carter, C Darke, et al.
Clinical Therapeutics
|
September 1, 2004
A randomized, double-blind, parallel-group comparison of controlled- and immediate-release oxybutynin chloride in urge urinary incontinence
Jack Barkin, Jacques Corcos, Sidney Radomski, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 215) with videos related to
Sort By:
Page
of 22
Tissue Antigens
|
July 1, 1997
A new HLA-B44 variant (B44BO [B*4408]) identified by serology
C Darke, J Street, H Fussell, et al.
The Journal of Rheumatology
|
December 1, 1986
Lowering of plasma isoxicam concentrations with acetylsalicylic acid
E M Grace, A A Mewa, G D Sweeney, et al.
Human Immunology
|
June 8, 2001
Analysis of the distribution of HLA-B alleles in populations from five continents
F Williams, A Meenagh, C Darke, et al.
Thyroid : Official Journal of the American Thyroid Association
|
October 19, 1999
Assessment of goiter in an area of endemic iodine deficiency
P P Smyth, C Darke, A B Parkes, et al.
European Journal of Endocrinology
|
April 1, 1996
Major histocompatibility complex class II and complement polymorphisms in postpartum thyroiditis
A B Parkes, C Darke, S Othman, et al.
BJU International
|
February 14, 2006
A double-blind randomized dose-response study comparing daily doses of 5, 10 and 15 mg controlled-release oxybutynin: balancing efficacy with severity of dry mouth
Jaques Corcos, Richard Casey, Allan Patrick, et al.
Leukemia
|
May 1, 1995
Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia
M T Dorak, G Owen, I Galbraith, et al.
Genes and Immunity
|
December 15, 2006
Non-B27 MHC associations of ankylosing spondylitis
A-M Sims, M Barnardo, I Herzberg, et al.
British Journal of Haematology
|
September 1, 2001
HFE mutations, iron deficiency and overload in 10,500 blood donors
H A Jackson, K Carter, C Darke, et al.
Clinical Therapeutics
|
September 1, 2004
A randomized, double-blind, parallel-group comparison of controlled- and immediate-release oxybutynin chloride in urge urinary incontinence
Jack Barkin, Jacques Corcos, Sidney Radomski, et al.
Page
of 22